| Stop & Shop Pharmacy #36 | |
| 672 Memorial Dr, Chicopee, Massachusetts 01020 | |
| (413) 593-3999 |
| Name | Stop & Shop Pharmacy #36 |
|---|---|
| Organization Name | Stop And Shop Supermarket Co Llc. |
| Location | 672 Memorial Dr, Chicopee, Massachusetts 01020 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (413) 593-3999 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).
Merge Healthcare Incorporated, a health IT solutions provider, today announced financial results for the fourth quarter and full year 2009.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.
› Verified 2 days ago
| NPI Number | 1144252024 |
| Organization Name | STOP AND SHOP SUPERMARKET CO LLC |
| Doing Business As | STOP AND SHOP PHARMACY #36 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 672 Memorial Dr, Chicopee, MA 01020 |
| Phone Number | 413-593-3999 |
News Archive
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).
Merge Healthcare Incorporated, a health IT solutions provider, today announced financial results for the fourth quarter and full year 2009.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.
› Verified 2 days ago
News Archive
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).
Merge Healthcare Incorporated, a health IT solutions provider, today announced financial results for the fourth quarter and full year 2009.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.
› Verified 2 days ago
Cvs Pharmacy #02339 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1176 Granby Rd, Chicopee, Massachusetts 01020 Phone: (413) 532-0097 | |
Cvs Pharmacy # 00843 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 235 Center Street, Chicopee, Massachusetts 01013 Phone: (413) 594-8156 | |
Cvs Pharmacy # 00693 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1616 Memorial Drive, Chicopee, Massachusetts 01020 Phone: (413) 532-3299 | |
Walgreens #7063 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 583 James St, Chicopee, Massachusetts 01020 Phone: (413) 493-1860 | |
Walgreens #17673 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 577 Meadow St, Chicopee, Massachusetts 01013 Phone: (413) 592-4696 |